NASDAQ:TBPH - Theravance Biopharma News Headlines

$23.12
+0.19 (+0.83 %)
(As of 09/16/2019 11:08 AM ET)
Today's Range
$22.75
Now: $23.12
$23.36
50-Day Range
$18.94
MA: $20.97
$24.08
52-Week Range
$15.18
Now: $23.12
$35.48
Volume9,544 shs
Average Volume202,184 shs
Market Capitalization$1.31 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.72

Headlines

Theravance Biopharma (NASDAQ TBPH) News Headlines

Source:
DateHeadline
Theravance Biopharma Inc (NASDAQ:TBPH) Short Interest UpdateTheravance Biopharma Inc (NASDAQ:TBPH) Short Interest Update
www.americanbankingnews.com - September 12 at 8:26 PM
$14.96 Million in Sales Expected for Theravance Biopharma Inc (NASDAQ:TBPH) This Quarter$14.96 Million in Sales Expected for Theravance Biopharma Inc (NASDAQ:TBPH) This Quarter
www.americanbankingnews.com - September 12 at 5:43 AM
Theravance Biopharma (NASDAQ:TBPH) Stock Rating Reaffirmed by Piper Jaffray CompaniesTheravance Biopharma (NASDAQ:TBPH) Stock Rating Reaffirmed by Piper Jaffray Companies
www.americanbankingnews.com - September 11 at 9:51 PM
Theravance Biopharma Breaks Above 200-Day Moving Average - Bullish for TBPHTheravance Biopharma Breaks Above 200-Day Moving Average - Bullish for TBPH
www.nasdaq.com - September 11 at 2:43 PM
Theravance Biopharma Target of Unusually Large Options Trading (NASDAQ:TBPH)Theravance Biopharma Target of Unusually Large Options Trading (NASDAQ:TBPH)
www.americanbankingnews.com - September 11 at 8:39 AM
Theravance Biopharma Inc (NASDAQ:TBPH) Expected to Announce Earnings of -$1.04 Per ShareTheravance Biopharma Inc (NASDAQ:TBPH) Expected to Announce Earnings of -$1.04 Per Share
www.americanbankingnews.com - September 10 at 1:01 PM
Theravance inhalable lung disease candidate shows encouraging action in early-stage studyTheravance inhalable lung disease candidate shows encouraging action in early-stage study
seekingalpha.com - September 9 at 1:52 PM
Theravance Biopharma Reports Positive Results from Phase 1 Clinical Trial of TD-8236, an Investigational, Lung-Selective, Inhaled Pan-Janus Kinase (JAK) Inhibitor for Inflammatory Lung DiseasesTheravance Biopharma Reports Positive Results from Phase 1 Clinical Trial of TD-8236, an Investigational, Lung-Selective, Inhaled Pan-Janus Kinase (JAK) Inhibitor for Inflammatory Lung Diseases
finance.yahoo.com - September 9 at 1:52 PM
Theravance Biopharma Inc (NASDAQ:TBPH) Receives Average Rating of "Buy" from AnalystsTheravance Biopharma Inc (NASDAQ:TBPH) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - September 7 at 2:39 AM
Reviewing NuCana (NASDAQ:NCNA) & Theravance Biopharma (NASDAQ:TBPH)Reviewing NuCana (NASDAQ:NCNA) & Theravance Biopharma (NASDAQ:TBPH)
www.americanbankingnews.com - September 6 at 2:54 PM
Theravance Biopharma: Gaining TractionTheravance Biopharma: Gaining Traction
seekingalpha.com - August 21 at 7:39 PM
How Theravance Biopharma, Inc. (NASDAQ:TBPH) Can Impact Your Portfolio VolatilityHow Theravance Biopharma, Inc. (NASDAQ:TBPH) Can Impact Your Portfolio Volatility
finance.yahoo.com - August 11 at 10:33 AM
Esperion (ESPR) Q2 Loss Wider Than Expected, Revenues BeatEsperion (ESPR) Q2 Loss Wider Than Expected, Revenues Beat
finance.yahoo.com - August 9 at 8:53 AM
Edited Transcript of TBPH earnings conference call or presentation 31-Jul-19 12:00pm GMTEdited Transcript of TBPH earnings conference call or presentation 31-Jul-19 12:00pm GMT
finance.yahoo.com - August 1 at 6:36 PM
Theravance (TBPH) Q2 Loss Narrower, Revenues Beat EstimatesTheravance (TBPH) Q2 Loss Narrower, Revenues Beat Estimates
finance.yahoo.com - August 1 at 6:36 PM
Theravance Biopharma, Inc. (TBPH) Q2 2019 Earnings Call TranscriptTheravance Biopharma, Inc. (TBPH) Q2 2019 Earnings Call Transcript
finance.yahoo.com - July 31 at 5:44 PM
Theravances ampreloxetine shows positive effect in mid-stage nOH study; shares up 2%Theravance's ampreloxetine shows positive effect in mid-stage nOH study; shares up 2%
seekingalpha.com - July 22 at 6:03 PM
Theravance Biopharma Reports New Data from Phase 2 Study of Ampreloxetine (TD-9855) in Oral Presentation at 32nd European Neurology CongressTheravance Biopharma Reports New Data from Phase 2 Study of Ampreloxetine (TD-9855) in Oral Presentation at 32nd European Neurology Congress
finance.yahoo.com - July 22 at 9:54 AM
How Much Did Theravance Biopharma, Inc.'s (NASDAQ:TBPH) CEO Pocket Last Year?How Much Did Theravance Biopharma, Inc.'s (NASDAQ:TBPH) CEO Pocket Last Year?
finance.yahoo.com - June 27 at 5:35 PM
After An Exaggerated Sell-Off, Theravance Should Recover SoonAfter An Exaggerated Sell-Off, Theravance Should Recover Soon
seekingalpha.com - June 24 at 5:26 PM
Theravance Biopharma Reports New Data from Phase 2 Study of Ampreloxetine (TD-9855) in Presentation at 2019 International Association of Parkinsonism and Related Disorders (IAPRD) World CongressTheravance Biopharma Reports New Data from Phase 2 Study of Ampreloxetine (TD-9855) in Presentation at 2019 International Association of Parkinsonism and Related Disorders (IAPRD) World Congress
finance.yahoo.com - June 18 at 5:48 PM
Introducing Theravance Biopharma (NASDAQ:TBPH), The Stock That Slid 54% In The Last Five YearsIntroducing Theravance Biopharma (NASDAQ:TBPH), The Stock That Slid 54% In The Last Five Years
finance.yahoo.com - June 17 at 6:32 PM
Theravance Biopharma and Mylan Expand YUPELRI® (revefenacin) Development and Commercialization Agreement to Include China and Adjacent TerritoriesTheravance Biopharma and Mylan Expand YUPELRI® (revefenacin) Development and Commercialization Agreement to Include China and Adjacent Territories
finance.yahoo.com - June 14 at 10:48 AM
Theravance Bio (TBPH) Down 27.7% Since Last Earnings Report: Can It Rebound?Theravance Bio (TBPH) Down 27.7% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - June 6 at 5:49 PM
Theravance Bios TD-1473 shows encouraging action in early-stage UC studyTheravance Bio's TD-1473 shows encouraging action in early-stage UC study
seekingalpha.com - May 21 at 11:36 AM
Oversold Conditions For Theravance Biopharma (TBPH)Oversold Conditions For Theravance Biopharma (TBPH)
www.nasdaq.com - May 20 at 12:35 PM
Theravance Biopharma Inc. (TBPH) Q1 2019 Earnings Call TranscriptTheravance Biopharma Inc. (TBPH) Q1 2019 Earnings Call Transcript
www.fool.com - May 15 at 12:13 AM
Theravance Biopharma Announces Data from Phase 1b Study of TD-1473 to be Featured in Oral Presentation at Digestive Disease Week (DDW) 2019Theravance Biopharma Announces Data from Phase 1b Study of TD-1473 to be Featured in Oral Presentation at Digestive Disease Week (DDW) 2019
www.prnewswire.com - May 14 at 9:50 AM
Theravance Biopharma (TBPH) Reports Q1 Loss, Lags Revenue EstimatesTheravance Biopharma (TBPH) Reports Q1 Loss, Lags Revenue Estimates
finance.yahoo.com - May 8 at 9:30 AM
Edited Transcript of TBPH earnings conference call or presentation 7-May-19 9:00pm GMTEdited Transcript of TBPH earnings conference call or presentation 7-May-19 9:00pm GMT
finance.yahoo.com - May 8 at 9:30 AM
Theravance Biopharma, Inc. Reports First Quarter 2019 Financial Results and Provides Business UpdateTheravance Biopharma, Inc. Reports First Quarter 2019 Financial Results and Provides Business Update
finance.yahoo.com - May 7 at 6:01 PM
Commit To Purchase Theravance Biopharma At $20, Earn 11.7% Annualized Using OptionsCommit To Purchase Theravance Biopharma At $20, Earn 11.7% Annualized Using Options
www.nasdaq.com - May 2 at 6:35 PM
Here’s What Hedge Funds Think About Theravance Biopharma Inc (TBPH)Here’s What Hedge Funds Think About Theravance Biopharma Inc (TBPH)
finance.yahoo.com - May 2 at 6:35 PM
Theravance Biopharma to Report First Quarter 2019 Financial Results on May 7Theravance Biopharma to Report First Quarter 2019 Financial Results on May 7
finance.yahoo.com - April 30 at 5:57 PM
Read This Before Buying Theravance Biopharma, Inc. (NASDAQ:TBPH) SharesRead This Before Buying Theravance Biopharma, Inc. (NASDAQ:TBPH) Shares
finance.yahoo.com - April 24 at 9:34 AM
Theravance Biopharma to Present at the 18th Annual Needham Healthcare ConferenceTheravance Biopharma to Present at the 18th Annual Needham Healthcare Conference
finance.yahoo.com - April 2 at 11:09 AM
Why Is Theravance Bio (TBPH) Down 7.9% Since Last Earnings Report?Why Is Theravance Bio (TBPH) Down 7.9% Since Last Earnings Report?
finance.yahoo.com - March 28 at 6:08 PM
Theravance Biopharma Announces Ampreloxetine (TD-9855) Phase 2 Study Results Selected for Oral Presentation at 32nd European Neurology CongressTheravance Biopharma Announces Ampreloxetine (TD-9855) Phase 2 Study Results Selected for Oral Presentation at 32nd European Neurology Congress
finance.yahoo.com - March 25 at 9:09 AM
Theravance Biopharma Announces First Patient Dosed in Phase 2b/3 Study of TD-1473 in Patients with Ulcerative ColitisTheravance Biopharma Announces First Patient Dosed in Phase 2b/3 Study of TD-1473 in Patients with Ulcerative Colitis
finance.yahoo.com - March 12 at 10:47 AM
Theravance Biopharma Inc.Theravance Biopharma Inc.
www.barrons.com - March 11 at 10:57 AM
Edited Transcript of TBPH earnings conference call or presentation 26-Feb-19 10:00pm GMTEdited Transcript of TBPH earnings conference call or presentation 26-Feb-19 10:00pm GMT
finance.yahoo.com - February 27 at 9:41 AM
Theravance Biopharma Inc (TBPH) Q4 2018 Earnings Conference Call TranscriptTheravance Biopharma Inc (TBPH) Q4 2018 Earnings Conference Call Transcript
www.fool.com - February 26 at 11:32 PM
Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business UpdateTheravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update
finance.yahoo.com - February 26 at 5:43 PM
Theravance Biopharma, Inc. (TBPH)Theravance Biopharma, Inc. (TBPH)
finance.yahoo.com - February 26 at 10:00 AM
Frontier Communications' (FTR) Q4 Earnings: What's in Store?Frontier Communications' (FTR) Q4 Earnings: What's in Store?
finance.yahoo.com - February 21 at 10:09 AM
Theravance Biopharma to Present at the 8th Annual SVB Leerink Global Healthcare ConferenceTheravance Biopharma to Present at the 8th Annual SVB Leerink Global Healthcare Conference
finance.yahoo.com - February 21 at 10:09 AM
Theravance Biopharma to Report Fourth Quarter and Full Year 2018 Financial Results on February 26Theravance Biopharma to Report Fourth Quarter and Full Year 2018 Financial Results on February 26
finance.yahoo.com - February 19 at 5:55 PM
What's in Store for Telefonica Brasil (VIV) in Q4 Earnings?What's in Store for Telefonica Brasil (VIV) in Q4 Earnings?
finance.yahoo.com - February 18 at 5:09 PM
Theravance Biopharma Announces First Patient Dosed in Registrational Phase 3 Study of Ampreloxetine (TD-9855) for the Treatment of Symptomatic Neurogenic Orthostatic HypotensionTheravance Biopharma Announces First Patient Dosed in Registrational Phase 3 Study of Ampreloxetine (TD-9855) for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension
finance.yahoo.com - January 28 at 9:33 AM
With $500M in reserve, biotech cuts 49 jobs to focus on maturing drug pipelineWith $500M in reserve, biotech cuts 49 jobs to focus on maturing drug pipeline
finance.yahoo.com - January 23 at 9:22 AM
This page was last updated on 9/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel